NCT06230848

Brief Summary

The aims of this pilot are to determine the feasibility and acceptability of the Multisensory early oral administration of human milk (M-MILK) intervention, recruitment, retention, and obtain data for sample size estimation. This study will advance nursing science and practice because it will inform our R01 RCT to examine the efficacy of M-MILK to attenuate adverse effects of early life toxic stress in preterm infants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 5, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 30, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 23, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 23, 2024

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

January 8, 2026

Completed
Last Updated

January 8, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

January 5, 2024

Results QC Date

November 21, 2025

Last Update Submit

December 17, 2025

Conditions

Keywords

stresspreterm infantsepigeneticsgut microbiomeparent-infant relationship

Outcome Measures

Primary Outcomes (11)

  • Feasibility of Intervention

    The count of participants who receive M-MILK in at least 50% of their scheduled M-MILK administrations. MILK will be considered feasible if M-MILK is implemented by nurses or parents after every hands-on care and during the beginning of a full gavage feeding at least 50% of the time.

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Acceptability of Intervention

    The percentage of parents who rate the intervention as very positive, slightly positive, or acceptable on a 5-point Likert scale.

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Retention

    Retention will be described by the number of post-discharge follow-up surveys completed.

    2 months corrected age

  • The Scarf Sign Cluster of the Neurobehavioral Assessment of the Preterm Infants Score

    The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for scarf sign ranges from 0-100, where higher scores indicate better neurodevelopmental performance.

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Variability in the Motor Development & Vigor Cluster of the Neurobehavioral Assessment of the Preterm Infants Score

    The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for motor development \& vigor ranges from 0-100, where higher scores indicate better neurodevelopmental performance.

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Popliteal Angle Cluster of the Neurobehavioral Assessment of the Preterm Infants Score

    The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for popliteal angle ranges from 0-100, where higher scores indicate better neurodevelopmental performance.

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Alertness and Orientation Cluster of the Neurobehavioral Assessment of the Preterm Infants Score

    The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for alertness and orientation ranges from 0-100, where higher scores indicate better neurodevelopmental performance.

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Irritability Cluster of the Neurobehavioral Assessment of the Preterm Infants Score

    The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for irritability ranges from 0-100, where higher scores indicate better neurodevelopmental performance.

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Quality of Cry Cluster of the Neurobehavioral Assessment of the Preterm Infants Score

    The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for quality of cry ranges from 0-100, where higher scores indicate better neurodevelopmental performance.

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Percent Sleep Cluster of the Neurobehavioral Assessment of the Preterm Infants Score

    The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for percent sleep ranges from 0-100, where higher scores indicate better neurodevelopmental performance.

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Early Feeding Skill Assessment Score

    EFS has 22 items (32-50 weeks PMA), summary scores, 5 subscales: respiratory regulation (range 5 - 15), oral-motor functioning (range 4 - 12), swallowing coordination (range 4 - 12), engagement (range 2 - 6), \& physiologic stability (range 4 - 12), where higher scores indicate better oral feeding skill development. The total score is the sum of the subscales and ranges from 19-57.

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

Secondary Outcomes (5)

  • Parent Stressor Scale: NICU Score

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Parent Discharge Readiness Score

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Breastmilk Pumping Rate

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Breastfeeding Rate

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Maternal Edinburgh Postnatal Depression Scale Score

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

Other Outcomes (3)

  • Variability in Gut Microbial Community Structure and Relative Abundance of SCFA- and Lactate- Producing Bacteria

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Variability in DNA Methylation of NR3C1 Promoter

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

  • Variability in DNA Methylation of HSD11B2 Promoter

    At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.

Study Arms (2)

Control

NO INTERVENTION

Infants in the control group will receive standard of care.

M-MILK

EXPERIMENTAL

Infants in the M-MILK group will receive the M-MILK intervention in addition to standard of care.

Other: Multisensory Early Oral Administration of Human Milk (M-MILK)

Interventions

M-MILK is implemented starting on day 3 of life, after every hands-on care, during the beginning of a full gavage feeding. Infants receive M-MILK in small droplets via a 1-ml syringe. M-MILK will cease upon oral feeding initiation. Infants will receive either mother's own milk or donor's milk based on availability. Infants may receive up to 1 mL of milk each time based on their cues and responses. The 1 mL volume intake is included as part of their oral caloric intake. M-MILK is provided by nurses or parents.

M-MILK

Eligibility Criteria

Age0 Years - 1 Year
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • born between 22 to 34 weeks gestational age and receiving mother's own milk and/or donor milk.

You may not qualify if:

  • receiving only formula, oral cavity defects, gastrointestinal defects, chromosomal abnormalities, severe cardiac defects that require surgery, or intraventricular hemorrhage grade III or IV

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loyola University Chicago

Maywood, Illinois, 60153, United States

Location

Results Point of Contact

Title
Dr. Thao Griffith
Organization
Loyola University Chicago

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 5, 2024

First Posted

January 30, 2024

Study Start

October 23, 2023

Primary Completion

October 23, 2024

Study Completion

October 23, 2024

Last Updated

January 8, 2026

Results First Posted

January 8, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations